(Q41096391)

26 September 2017

Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial (English)

1 reference

multicenter clinical trial

26 September 2017

0 references

0 references

author

Greg Knoll

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608067%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Dean A Fergusson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608067%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Michaël Chassé

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608067%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Timothy Ramsay

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608067%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

5

George Wells

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608067%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Paul Hebert

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608067%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Lee Anne Tibbles

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608067%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Darin Treleaven

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608067%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

David Holland

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608067%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Christine White

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608067%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Norman Muirhead

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608067%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Marcelo Cantarovich

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608067%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Michel Paquet

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608067%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Bryce Kiberd

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608067%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Sita Gourishankar

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608067%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Jean Shapiro

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608067%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Ramesh Prasad

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608067%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Edward Cole

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608067%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Helen Pilmore

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608067%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Valerie Cronin

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608067%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Debora Hogan

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608067%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

John Gill

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608067%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

publication date

21 October 2015

1 reference

The Lancet: Diabetes & Endocrinology

26 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608067%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608067%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608067%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

318-326

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608067%20AND%20SRC:MED&resulttype=core&format=json

The burden of chronic kidney disease in renal transplant recipients

7 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900368-X

7 January 2021

Proteinuria in kidney transplant recipients: prevalence, prognosis, and evidence-based management

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900368-X

7 January 2021

Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900368-X

7 January 2021

No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900368-X

7 January 2021

Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900368-X

7 January 2021

Antihypertensives for kidney transplant recipients: systematic review and meta-analysis of randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900368-X

7 January 2021

Use of renin-angiotensin-aldosterone system inhibitors within the first eight to twelve weeks after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900368-X

7 January 2021

The Canadian ACE-inhibitor trial to improve renal outcomes and patient survival in kidney transplantation study design

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900368-X

7 January 2021

Estimating GFR using serum beta trace protein: accuracy and validation in kidney transplant and pediatric populations.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900368-X

7 January 2021

Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900368-X

7 January 2021

Angiotensin II blockade in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900368-X

7 January 2021

ACE inhibitors and persistent left ventricular hypertrophy after renal transplantation: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900368-X

7 January 2021

Effects of ACE inhibitors on long-term outcome of renal transplant recipients: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900368-X

7 January 2021

UK Renal Registry 16th annual report: chapter 11 blood pressure profile of prevalent patients receiving renal replacement therapy in 2012: national and centre-specific analyses

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900368-X

7 January 2021

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900368-X

7 January 2021

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900368-X

7 January 2021

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900368-X

7 January 2021

Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900368-X

7 January 2021

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900368-X

7 January 2021

Assessment and management of hypertension in transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900368-X

7 January 2021

Non-immune interventions to protect kidney allografts in the long term

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900368-X

7 January 2021

Early use of renin-angiotensin-aldosterone system inhibitors after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900368-X

7 January 2021

Angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900368-X

7 January 2021

Hypertension in the kidney transplant recipient.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900368-X

7 January 2021

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900368-X

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900368-X

7 January 2021

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900368-X

7 January 2021

Anemia after kidney transplantation; its prevalence, risk factors, and independent association with graft and patient survival: a time-varying analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900368-X

7 January 2021

Influence of anemia on patient and graft survival after renal transplantation: results from the French DIVAT cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900368-X

7 January 2021

US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900368-X

7 January 2021

KDIGO clinical practice guideline for the care of kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900368-X

7 January 2021

10.1016/S2213-8587(15)00368-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26608067%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

1 reference